Nexalin Technology, Inc. to acquire PONM, Inc.

Nexalin Technology, Inc. has agreed to acquire PONM, Inc. in a strategic acquisition within the Healthcare sector. The transaction, valued at 1.3 million USD, was settled entirely through the exchange of shares. Both the acquiring entity and the target company are based in the United States, creating a domestic consolidation of assets in the medical technology space. The deal was announced on 19 May 2026, following its completion on 14 May 2026, indicating a rapid execution of the agreement between the two parties.

The consideration structure relies solely on equity, suggesting a focus on long-term alignment between the combined entities. As a strategic acquisition, this move integrates the capabilities of PONM, Inc. into the broader portfolio of Nexalin Technology, Inc. without the involvement of external debt or cash outlays. The transaction has now reached its final stage, with all necessary conditions for the transfer of ownership satisfied. The transaction is subject to regulatory approval.